Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean A Fergusson

Showing results (1-10 of 399) with videos related to

Pageof 40
Sort By:
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|July 9, 2009
Minimizing and accounting for the impact of rescue therapies in clinical trialsDean A Fergusson, Tim Ramsay
Seminars in Nuclear Medicine|March 2, 2019
Diagnostic Accuracy StudiesMichaël Chassé, Dean A Fergusson
JAMA|April 30, 2008
The future of clinical trials evaluating blood substitutesDean A Fergusson, Lauralyn McIntyre
JAMA Internal Medicine|April 7, 2017
Blood Donor Characteristics On Transfusion Outcomes-Should Obesity Be Assessed in Future Clinical Trials?-ReplyMichaël Chassé, Dean A Fergusson
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|April 9, 2005
The health(y) cost of erythropoietin in orthopedic surgeryDean A Fergusson, Paul Hébert
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 28, 2010
Are we keeping research participants safe enough?Paul C Hébert, Dean A Fergusson
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 24, 2008
Exaggeration of treatment benefits using the "event-based" number needed to treatShawn D Aaron, Dean A Fergusson
Vox Sanguinis|March 6, 2003
Evaluation of a universal leukoreduction program in CanadaPaul C Hébert, Dean A Fergusson,
JAMA|September 24, 2002
Red blood cell transfusions in critically ill patientsPaul C Hébert, Dean A Fergusson
JAMA|October 7, 2004
Do transfusions get to the heart of the matter?Paul C Hébert, Dean A Fergusson
Pageof 40

Showing results (1-10 of 399) with videos related to

Sort By:
Pageof 40
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|July 9, 2009
Minimizing and accounting for the impact of rescue therapies in clinical trialsDean A Fergusson, Tim Ramsay
Seminars in Nuclear Medicine|March 2, 2019
Diagnostic Accuracy StudiesMichaël Chassé, Dean A Fergusson
JAMA|April 30, 2008
The future of clinical trials evaluating blood substitutesDean A Fergusson, Lauralyn McIntyre
JAMA Internal Medicine|April 7, 2017
Blood Donor Characteristics On Transfusion Outcomes-Should Obesity Be Assessed in Future Clinical Trials?-ReplyMichaël Chassé, Dean A Fergusson
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|April 9, 2005
The health(y) cost of erythropoietin in orthopedic surgeryDean A Fergusson, Paul Hébert
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 28, 2010
Are we keeping research participants safe enough?Paul C Hébert, Dean A Fergusson
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 24, 2008
Exaggeration of treatment benefits using the "event-based" number needed to treatShawn D Aaron, Dean A Fergusson
Vox Sanguinis|March 6, 2003
Evaluation of a universal leukoreduction program in CanadaPaul C Hébert, Dean A Fergusson,
JAMA|September 24, 2002
Red blood cell transfusions in critically ill patientsPaul C Hébert, Dean A Fergusson
JAMA|October 7, 2004
Do transfusions get to the heart of the matter?Paul C Hébert, Dean A Fergusson
Pageof 40